The price-to-earnings ratio for Metlife Inc (NYSE: MET) is above average at 22.98x. The 36-month beta value for MET is also noteworthy at 1.04. There are mixed opinions on the stock, with 11 analysts rating it as a “buy,” 1 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”

The average price estimated by analysts for MET is $77.31, which is $14.8 above than the current price. The public float for MET is 622.09M, and at present, short sellers hold a 1.30% of that float. The average trading volume of MET on November 21, 2023 was 3.66M shares.

MET) stock’s latest price update

Metlife Inc (NYSE: MET)’s stock price has dropped by -0.06 in relation to previous closing price of 62.55. Nevertheless, the company has seen a gain of 3.39% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-10 that The Summer, 2023 edition of Fortune Magazine revealed 500 biggest U.S. companies by revenue. Dogcatcher’s quest to sniff-out the best dividend buys focused on 68 industry leaders using YCharts 11/8/23. Those 68 industry leaders were segmented into 21 business sectors ranging (alphabetically) from apparel to wholesalers. Three of the 68 are not listed on U.S. exchanges. Their data was excluded. 58 dividend yielding stocks led those 68 industry leaders and ranged 0.19% to 9.56% in annual-yield and ranged -1.29% to 54.34% in broker-estimated one-year price-target-upsides by YCharts 11/8/23 reckoning.

MET’s Market Performance

Metlife Inc (MET) has seen a 3.39% rise in stock performance for the week, with a 3.98% gain in the past month and a 1.94% surge in the past quarter. The volatility ratio for the week is 1.66%, and the volatility levels for the past 30 days are at 2.03% for MET. The simple moving average for the last 20 days is 3.78% for MET’s stock, with a simple moving average of 3.28% for the last 200 days.

Analysts’ Opinion of MET

Many brokerage firms have already submitted their reports for MET stocks, with Barclays repeating the rating for MET by listing it as a “Overweight.” The predicted price for MET in the upcoming period, according to Barclays is $71 based on the research report published on November 17, 2023 of the current year 2023.

MET Trading at 0.84% from the 50-Day Moving Average

After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.20% of loss for the given period.

Volatility was left at 2.03%, however, over the last 30 days, the volatility rate increased by 1.66%, as shares surge +6.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.40% lower at present.

During the last 5 trading sessions, MET rose by +3.39%, which changed the moving average for the period of 200-days by -10.43% in comparison to the 20-day moving average, which settled at $60.43. In addition, Metlife Inc saw -13.62% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MET starting from DEBEL MARLENE, who sale 9,391 shares at the price of $63.18 back on Aug 09. After this action, DEBEL MARLENE now owns 77,638 shares of Metlife Inc, valued at $593,323 using the latest closing price.

PAPPAS BILL, the EVP, Global Tech. & Ops. of Metlife Inc, sale 2,857 shares at $70.96 during a trade that took place back on Mar 02, which means that PAPPAS BILL is holding 48,915 shares at $202,733 based on the most recent closing price.

Stock Fundamentals for MET

Current profitability levels for the company are sitting at:

The net margin for Metlife Inc stands at +3.63. The total capital return value is set at 1.00, while invested capital returns managed to touch 3.88. Equity return is now at value 9.12, with 0.36 for asset returns.

Based on Metlife Inc (MET), the company’s capital structure generated 69.14 points at debt to equity in total, while total debt to capital is 40.88. Total debt to assets is 2.80, with long-term debt to equity ratio resting at 68.49. Finally, the long-term debt to capital ratio is 40.50.

When we switch over and look at the enterprise to sales, we see a ratio of 0.70, with the company’s debt to enterprise value settled at 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.57.

Conclusion

In summary, Metlife Inc (MET) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.